Oral microbiota and oral squamous cell carcinoma: a review of their relation and carcinogenic mechanisms

Oral microbiota and oral squamous cell carcinoma: a review of their relation and carcinogenic mechanisms

Oral Squamous Cell Carcinoma (OSCC) is the most common type of head and neck cancer worldwide. Emerging research suggests a strong association between OSCC and the oral microbiota, a diverse community of bacteria, fungi, viruses, and archaea. Pathogenic bacteria, in particular Porphyromonas gingival...

Full description

Bibliographic Details
Main Authors:	Bayu Indra Sukmana, Raed Obaid Saleh, Maryam Abdulrahman Najim, Hasan S. AL-Ghamdi, Harun Achmad, Mais Mazin Al-Hamdani, Abbas AY. Taher, Ali Alsalamy, Mansoor Khaledi, Kasra Javadi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	oral microbiota oral squamous cell carcinoma carcinogenic mechanisms Porphyromonas gingivalis Fusobacterium nucleatum Candida albicans
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1319777/full

Similar Items

Oral Microbiota and Salivary Levels of Oral Pathogens in Gastro-Intestinal Diseases: Current Knowledge and Exploratory Study
by: Maria Contaldo, et al.
Published: (2021-05-01)

Oral microbiota–host interaction: the chief culprit of alveolar bone resorption
by: Jingyu Xu, et al.
Published: (2024-02-01)

Fusobacterium nucleatum bacteremia complicated with intracranial Porphyromonas gingivalis and HSV-1 infection: a case report and literature review
by: Sumei Wang, et al.
Published: (2024-02-01)

The Contribution of the Human Oral Microbiome to Oral Disease: A Review
by: Austin Gregory Morrison, et al.
Published: (2023-01-01)

Thermoreversible gel for intrapocket delivery of green tea catechin as a local drug delivery system: An original research
by: M Yuvaraja, et al.
Published: (2016-01-01)

Co-Culture of <i>P</i>. <i>gingivalis</i> and <i>F</i>. <i>nucleatum</i> Synergistically Elevates IL-6 Expression via TLR4 Signaling in Oral Keratinocytes
by: Lucas Yáñez, et al.
Published: (2024-03-01)

Assessment of Minimum Inhibitory Concentration and Anti-biofilm Activity of Plectranthus Amboinicus Solvent Extract against Pure Strains of Putative Periodontal Pathogens: An In-vitro Study
by: S Lavanya, et al.
Published: (2024-04-01)

Antibacterial efficacy of Trachyspermum ammi Oil against Porphyromonas gingivalis, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans: An in vitro study
by: Puja C Yavagal, et al.
Published: (2022-01-01)

Effect of gallium-arsenic laser on photosensitized periodontopathic anaerobic organisms: An in vitro study
by: Setu Mathur, et al.
Published: (2016-01-01)

Porphyromonas gingivalis diffusible signaling molecules enhance Fusobacterium nucleatum biofilm formation via gene expression modulation
by: Yukiko Yamaguchi-Kuroda, et al.
Published: (2023-12-01)

Antimicrobial efficacy of different herbal extracts against root canal pathogens - An in vitro study
by: Maryam Raoof, et al.
Published: (2023-01-01)

Evaluation of the antibacterial activity of Elsholtzia ciliate essential oil against halitosis-related Fusobacterium nucleatum and Porphyromonas gingivalis
by: Fengjiao Li, et al.
Published: (2023-08-01)

Periodontopathogens <i>Porphyromonas gingivalis</i> and <i>Fusobacterium nucleatum</i> and Their Roles in the Progression of Respiratory Diseases
by: Tao Shi, et al.
Published: (2023-08-01)

Effect of Different Oligosaccharides on Streptococcus mutans, Porphyromonas gingivalis and Clostridium nucleatus in Vitro
by: Yun YANG, et al.
Published: (2023-03-01)

Phages are unrecognized players in the ecology of the oral pathogen Porphyromonas gingivalis
by: Cole B. Matrishin, et al.
Published: (2023-07-01)

In vitro assessment of the antimicrobial activity of tetracycline hydrochloride diluted in three different vehicles against Porphyromonas gingivalis, Prevotella intermedia, and Fusobacterium nucleatum
by: Andrea Escalante-Herrera, et al.
Published: (2022-01-01)

Risk Factors and Immunoinflammatory Mechanisms Leading to Atherosclerosis: Focus on the Role of Oral Microbiota Dysbiosis
by: Riccardo Mattia Ricciardi, et al.
Published: (2023-06-01)

Effectiveness of an oral care tablet containing kiwifruit powder in reducing oral bacteria in tongue coating: A crossover trial
by: Yuki Matsumura, et al.
Published: (2020-04-01)

Oral microbiota and oral cancer: Review
by: Mariam Z. Kakabadze, et al.
Published: (2020-07-01)

Oral Microbial Profile Analysis in Patients with Oral and Pharyngeal Cancer Reveals That Tumoral <i>Fusobacterium nucleatum</i> Promotes Oral Cancer Progression by Activating YAP
by: Yuki Yamamoto, et al.
Published: (2023-12-01)

Oral <i>Porphyromonas gingivalis</i> and <i>Fusobacterium nucleatum</i> Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia
by: Maria Cristina Curia, et al.
Published: (2022-08-01)

Molecular Mechanisms Leading from Periodontal Disease to Cancer
by: Bartosz Kamil Sobocki, et al.
Published: (2022-01-01)

Research progress on the relationship between periodontal pathogens and colorectal cancer
by: XIAN Wenpan, et al.
Published: (2023-07-01)

Determination and comparison of antimicrobial activity of aqueous and ethanolic extracts of Amorphophallus paeoniifolius on periodontal pathogens: An in vitro study
by: Aarati Nayak, et al.
Published: (2023-01-01)

Involvement of <i>Fusobacterium</i> Species in Oral Cancer Progression: A Literature Review Including Other Types of Cancer
by: Natsumi Fujiwara, et al.
Published: (2020-08-01)

Oral microbiome associated with differential ratios of Porphyromonas gingivalis and Streptococcus cristatus
by: Qingguo Wang, et al.
Published: (2024-02-01)

Mechanisms of Porphyromonas gingivalis to translocate over the oral mucosa and other tissue barriers
by: Caroline A. de Jongh, et al.
Published: (2023-12-01)

A Plausible Proposition of CCL20-Related Mechanism in <i>Fusobacterium nucleatum</i>-Associated Oral Carcinogenesis
by: Devi Prasad Mandal, et al.
Published: (2021-11-01)

Growth Conditions Influence <i>Lactobacillus</i> Cell-Free Supernatant Impact on Viability, Biofilm Formation, and Co-Aggregation of the Oral Periodontopathogens <i>Fusobacterium nucleatum</i> and <i>Porphyromonas gingivalis</i>
by: Paola Zanetta, et al.
Published: (2023-03-01)

Identification of Potential Candidate Genes of Oral Cancer in Response to Chronic Infection With Porphyromonas gingivalis Using Bioinformatical Analyses
by: Fengxue Geng, et al.
Published: (2019-02-01)

<i>Osmunda japonica</i> Extract Suppresses Pro-Inflammatory Cytokines by Downregulating NF-κB Activation in Periodontal Ligament Fibroblasts Infected with Oral Pathogenic Bacteria
by: Jihyoun Seong, et al.
Published: (2020-04-01)

Virulence Factors of the Periodontal Pathogens: Tools to Evade the Host Immune Response and Promote Carcinogenesis
by: Linah A. Shahoumi, et al.
Published: (2023-01-01)

The Role of the Oral Microbiota in the Etiopathogenesis of Oral Squamous Cell Carcinoma
by: Tereza Vyhnalova, et al.
Published: (2021-07-01)

The Roles of Periodontal Bacteria in Atherosclerosis
by: Xiaofei Huang, et al.
Published: (2023-08-01)

Association between Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma and Periodontopathic Bacteria: A Cross-Sectional Pilot Study
by: Ryo Takuma, et al.
Published: (2023-03-01)

Oral-gut microbial transmission promotes diabetic coronary heart disease
by: Yiwen Li, et al.
Published: (2024-04-01)

The Potential of Colonic Tumor Tissue <i>Fusobacterium nucleatum</i> to Predict Staging and Its Interplay with Oral Abundance in Colon Cancer Patients
by: Pamela Pignatelli, et al.
Published: (2021-03-01)

The use of mucoadhesive oral patches containing epigallocatechin-3-gallate to treat periodontitis: an in vivo study
by: Dur Muhammad Lashari, MPil, et al.
Published: (2022-12-01)

Periodontal pathogens as a risk factor for oral squamous cell carcinoma
by: A. E. Kasimov, et al.
Published: (2021-11-01)

Analysis of Chemical Structure and Antibiofilm Properties of Exopolysaccharides from <i>Lactiplantibacillus plantarum</i> EIR/IF-1 Postbiotics
by: Basar Karaca, et al.
Published: (2022-11-01)